FY5-42196-46600
4 vaccinations
1 coded response
50 check-ins
0 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 160 / PA
- Registered
- 2021-03-03
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-03
Registered in v-safe
-
2021-03-05
Dose 1 — Pfizer-BioNTech
- 2021-03-05
- 2021-03-06
-
2021-03-07
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Rash, not including the immediate area around the injection siteAdult check-in
- 2021-03-08
- 2021-03-09
- 2021-03-10
- 2021-03-11
- 2021-03-12
- 2021-03-19
-
2021-03-26
Dose 2 — Pfizer-BioNTech
- 2021-03-26
-
2021-03-27
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Headache, Fatigue or tirednessAdult check-in
- 2021-03-28
- 2021-03-30
- 2021-03-31
- 2021-04-01
- 2021-04-02
- 2021-04-10
- 2021-04-16
- 2021-04-23
- 2021-04-30
- 2021-05-08
- 2021-06-27
- 2021-09-24
-
2021-11-16
Dose 3 — Pfizer-BioNTech
-
2021-11-17
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain · Headache, Fatigue or tiredness, NauseaAdult check-in
- 2021-11-18
- 2021-11-19
- 2021-11-21
- 2021-11-22
- 2021-11-23
- 2021-11-30
- 2021-12-10
- 2021-12-14
- 2021-12-21
- 2021-12-30
- 2022-02-15
- 2022-05-17
- 2022-11-16
-
2022-11-18
Dose 4 — Pfizer-BioNTech
-
2022-11-19
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Site: Pain · Headache, Fatigue or tirednessAdult check-in
- 2022-11-20
- 2022-11-21
- 2022-11-22
- 2022-11-23
- 2022-11-24
- 2022-11-25
- 2022-12-02
- 2022-12-09
- 2022-12-16
- 2022-12-25
- 2022-12-30
-
2023-02-17
Survey response — 3 months, dose 4MedDRA: Ageusia, Anosmia — Feeling: GoodMedDRA releases: 2024-11
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-05 | Pfizer-BioNTech | |
| 2 | 2021-03-26 | Pfizer-BioNTech | |
| 3 | 2021-11-16 | Pfizer-BioNTech | No |
| 4 | 2022-11-18 | Pfizer-BioNTech | No |
Free text
None.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Ageusia | · | · | ✓ |
| SD | Anosmia | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release